CasLoc logo
All Cases PTAB Litigations UPC Oppositions

GILEAD SCIENCES, INC. v. NATCO PHARMA LIMITED

2:11-cv-04969

Overview

Case Number 2:11-cv-04969
Filing Date 2011-08-29
Status Terminated
Termination Date 2011-09-12
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement

Parties

Defendant

NATCO PHARMA INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

NATCO PHARMA LIMITED NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

F. HOFFMANN-LA ROCHE LTD. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

GENENTECH, INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

GILEAD SCIENCES, INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

HOFFMANN-LA ROCHE INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 2 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 5 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (2): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (5 found):
U.S. Courts: 5
U.S. District Court 2017-07-28
1:17-cv-01041

CG Technology Development, LLC v. FanDuel, Inc.

U.S. Family Sibling (["USRE39818", "US6899628", "US9111417", "US8641511", "US8342924", "US7029394", "US6884166", "US7534169", "US8771058", "US8814664", "US9355518", "US9306952"])
Status: DED
U.S. District Court 2017-07-28
1:17-cv-01040

CG Technology Development, LLC v. DraftKings, Inc.

U.S. Family Sibling (["USRE39818", "US6899628", "US9111417", "US8641511", "US8342924", "US7029394", "US6884166", "US7534169", "US9355518", "US9306952"])
Status: DED
U.S. District Court 2016-04-15
2:16-cv-00871

CG Technology Development, LLC v. bwin.party digital entertainment PLC

U.S. Family Sibling (["USRE39818", "US6899628", "US7534169", "US6979267", "US8342924", "US7029394", "US9111417", "US8771058", "US8814664", "US9355518", "US9306952"])
Status: NVD
U.S. District Court 2013-05-23
13-1418

Gilead Sciences, Inc. v. Natco Pharma Limited

Asserted Patent
Status: CAFC
U.S. District Court 2011-03-15
2:11-cv-01455

GILEAD SCIENCES, INC. v. NATCO PHARMA LIMITED

Asserted Patent
Status: NJD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5763483
Carbocyclic compounds
Filed: 1996-12-27
Issued: 1998-06-09
Expired (Term Ended)
Expires: 2016-12-27

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(3 total)
Pleading / Complaint

COMPLAINT against NATCO PHARMA INC., NATCO PHARMA LIMITED ( Filing fee $ 350 receipt number 3903173.) NONE., filed by GILEAD SCIENCES, INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC., F. HOFFMANN-LA ROCHE LTD.. (Attachments: # 1 Summons to Natco Pharma Inc, # 2 Summons to Natco Pharma Limited, # 3 Civil Cover Sheet)(ld, ) (Additional attachment(s) added on 8/31/2011: # 4 Form AO 120) (ld). (Entered: 08/31/2011)

Entry #1 • 2011-08-29
Attachment
Pleading / Complaint

COMPLAINT against NATCO PHARMA INC., NATCO PHARMA LIMITED ( Filing fee $ 350 receipt number 3903173.) NONE., filed by GILEAD SCIENCES, INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC., F. HOFFMANN-LA ROCHE LTD.. (Attachments: # 1 Summons to Natco Pharma Inc, # 2 Summons to Natco Pharma Limited, # 3 Civil Cover Sheet)(ld, ) (Additional attachment(s) added on 8/31/2011: # 4 Form AO 120) (ld). (Entered: 08/31/2011)

Entry #1 • 2011-08-29
Attachment
Pleading / Complaint

COMPLAINT against NATCO PHARMA INC., NATCO PHARMA LIMITED ( Filing fee $ 350 receipt number 3903173.) NONE., filed by GILEAD SCIENCES, INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC., F. HOFFMANN-LA ROCHE LTD.. (Attachments: # 1 Summons to Natco Pharma Inc, # 2 Summons to Natco Pharma Limited, # 3 Civil Cover Sheet)(ld, ) (Additional attachment(s) added on 8/31/2011: # 4 Form AO 120) (ld). (Entered: 08/31/2011)

Entry #1 • 2011-08-29
PACER Document

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc